Lemierre's syndrome

(Redirected from Lemierre syndrome)
Jump to navigation Jump to search

WikiDoc Resources for Lemierre's syndrome

Articles

Most recent articles on Lemierre's syndrome

Most cited articles on Lemierre's syndrome

Review articles on Lemierre's syndrome

Articles on Lemierre's syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Lemierre's syndrome

Images of Lemierre's syndrome

Photos of Lemierre's syndrome

Podcasts & MP3s on Lemierre's syndrome

Videos on Lemierre's syndrome

Evidence Based Medicine

Cochrane Collaboration on Lemierre's syndrome

Bandolier on Lemierre's syndrome

TRIP on Lemierre's syndrome

Clinical Trials

Ongoing Trials on Lemierre's syndrome at Clinical Trials.gov

Trial results on Lemierre's syndrome

Clinical Trials on Lemierre's syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Lemierre's syndrome

NICE Guidance on Lemierre's syndrome

NHS PRODIGY Guidance

FDA on Lemierre's syndrome

CDC on Lemierre's syndrome

Books

Books on Lemierre's syndrome

News

Lemierre's syndrome in the news

Be alerted to news on Lemierre's syndrome

News trends on Lemierre's syndrome

Commentary

Blogs on Lemierre's syndrome

Definitions

Definitions of Lemierre's syndrome

Patient Resources / Community

Patient resources on Lemierre's syndrome

Discussion groups on Lemierre's syndrome

Patient Handouts on Lemierre's syndrome

Directions to Hospitals Treating Lemierre's syndrome

Risk calculators and risk factors for Lemierre's syndrome

Healthcare Provider Resources

Symptoms of Lemierre's syndrome

Causes & Risk Factors for Lemierre's syndrome

Diagnostic studies for Lemierre's syndrome

Treatment of Lemierre's syndrome

Continuing Medical Education (CME)

CME Programs on Lemierre's syndrome

International

Lemierre's syndrome en Espanol

Lemierre's syndrome en Francais

Business

Lemierre's syndrome in the Marketplace

Patents on Lemierre's syndrome

Experimental / Informatics

List of terms related to Lemierre's syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Lemierre's syndrome (or Lemierre's disease) is a disease usually caused by the bacterium Fusobacterium necrophorum, and occasionally by other members of the genus Fusobacterium (F. nucleatum, F. mortiferum and F. varium etc.) and usually affects young, healthy adults. Fusobacteria are normal inhabitants of the oropharyngeal flora. The infection leads to inflammation of and formation of a thrombus (blood clot) in the internal jugular vein. Many of the resulting symptoms are due to the septic emboli that break off from this initial area and travel through the blood to other areas of the body. Symptoms of Lemierre's syndrome include sore throat, extreme lethargy, fever, generalized body weakness, rigors, and swollen cervical lymph nodes. The mainstay of therapy for Lemierre's syndrome is antimicrobial therapy. Lemierre's disease is a very rare disease with only approximately 160 cases in the last 40 years.

Historial Perspective

Sepsis following from a throat infection was described by Scottmuller in 1918.[1] However it was Andre Lemierre, in 1936, who published a series of 20 cases where throat infections were followed by identified anaerobic septicemia, of whom 18 patients died.[2]

Pathophysiology

Microscopic Pathology

Fusobacterium necrophorum

  • It is a nonmotile, filamentous, nonfusiform pleomorphic non-spore-forming obligate anaerobic gram negative rod.
  • Normal microbiota of the oropharynx, GI tract, and genitourinary tract.
  • It is not known why F. necrophorum penetrates mucosa in some patients.
  • Reduced host defense (EBV); synergistic, pathogenic complex with other bacteria.

Differentiating Lemierre's Syndrome from Other Diseases

Lemierre's disease needs to be differentiated from the following diseases:

  • Descending necrotizing mediastinitis
  • Meningitis (mostly in children with otitis media)
  • Beware false positive chlamydia PCR

Epidemiology and Demographics

Age

Diagnosis

Symptoms

The first symptoms are a sore throat, extreme lethargy, fever, and general body weakness, but after a week or two these symptoms are followed by a spiked fever, rigors, swollen cervical lymph nodes and septicemia (infection of the blood) which can cause complications in other parts of the body including abscesses of lung, brain, and other organs, kidney failure and also effects on liver and joints if untreated.

Physical Examination

Throat

Ipsilateral neck tenderness parallel with sternocleidomastoid muscle

Lungs

Metastatic abscesses mainly to lungs (85%), but also joints (26%)

Abdomen

Abdominal pain 2nd to microabscesses vs. thrombophlebitis of abdomino- pelvic veins

Medical Therapy

Lemierre's syndrome is easily treated with antibiotics, but because sore throats are most commonly caused by viruses, for which antibiotic treatment is unnecessary, such treatment is not usual in the first phase of the disease. Lemierre's disease proves that, rarely, antibiotics are sometimes needed for 'sore throats'.[3] If a persistent sore throat, with the symptoms are found, physicians are cautioned to screen for Lemierre's syndrome. Fusobacterium necrophorum is generally highly susceptible to beta-lactam antibiotics, metronidazole, clindamycin and third generation cephalosporins while the other fusobacteria have varying degrees of resistance to beta-lactams and clindamycin.

Antimicrobial Regimen

  • Septic jugular thrombophlebitis (Lemierre's syndrome)[4]
  • 1. Causative pathogens
  • Fusobacterium
  • Viridans and other streptococci
  • Staphylococcus
  • Peptostreptococcus
  • Bacteroides
  • Other oral anaerobes
  • 2. Empiric antimicrobial therapy
  • 2.1 Immunocompetent host
  • 2.2 Immunocompromised host

Incidence

Lemierre's syndrome is currently a very rare disease, but was quite common in the early 20th century before the discovery of penicillin. The reduced use of routine antibiotics for sore throats by doctors may have increased the risk of this disease, with 19 cases in 1997 and 34 cases in 1999 reported in the UK.[3]. The incidence rate is currently 0.8 cases per million in the general population,[5] leading it to be termed the "forgotten disease".[6] The mortality rate was 90% prior to antibiotic therapy,[2] but is now generally quoted as 15% with proper medical treatment, although one series of cases reported mortality as low as 6.4%.[7]

References

  • Shah SA, Ghani R (2005). "Lemierre's syndrome: a forgotten complication of oropharyngeal infection". Journal of Ayub Medical College, Abbottabad : JAMC. 17 (1): 30–3. PMID 15929523.
  • Cheung WY, Bellas J (2007). "Case report: Lemierre syndrome presenting with fever and pharyngitis". American family physician. 75 (7): 979–80. PMID 17429891.

Footnotes

  1. Schottmuller H (1918). "Ueber die Pathogenität anaërober Bazillen". Dtsch Med Wochenschr (in German). 44: 1440.
  2. 2.0 2.1 Lemierre A (1936). "On certain septicemias due to anaerobic organisms". Lancet. 1: 701–3.
  3. 3.0 3.1 UK Chief Medical Officer Update 29 Feb 2001 (CMO Update29 Feb 2001)
  4. Hall, Jesse (2015). Principles of critical care. New York: McGraw-Hill Education. ISBN 978-0071738811.
  5. Sibai K, Sarasin F (2004). "[Lemierre syndrome: a diagnosis to keep in mind]". Revue médicale de la Suisse romande (in French). 124 (11): 693–5. PMID 15631168.
  6. Weesner CL, Cisek JE (1993). "Lemierre syndrome: the forgotten disease". Annals of emergency medicine. 22 (2): 256–8. PMID 8427443.
  7. Chirinos JA, Lichtstein DM, Garcia J, Tamariz LJ (2002). "The evolution of Lemierre syndrome: report of 2 cases and review of the literature". Medicine (Baltimore). 81 (6): 458–65. PMID 12441902.


Template:WikiDoc Sources